BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas. - Amayiri N; Obeidat M; Laban DA; Musharbash A; Al-Hussaini M; Maraqa B; Ibrahimi A; Sarhan N; Bouffet E (Pediatric blood & cancer, 2024)